nodes	percent_of_prediction	percent_of_DWPC	metapath
Duloxetine—HTR2C—Amine ligand-binding receptors—ADRB1—periodontitis	0.0118	0.0118	CbGpPWpGaD
Duloxetine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.011	0.011	CbGpPWpGaD
Duloxetine—NPY1R—G alpha (i) signalling events—CCR2—periodontitis	0.0108	0.0108	CbGpPWpGaD
Duloxetine—HTR2A—Amine ligand-binding receptors—ADRB1—periodontitis	0.0102	0.0102	CbGpPWpGaD
Duloxetine—NPY1R—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.00999	0.00999	CbGpPWpGaD
Duloxetine—NPY1R—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	0.00995	0.00995	CbGpPWpGaD
Duloxetine—HTR6—G alpha (s) signalling events—VIP—periodontitis	0.00956	0.00956	CbGpPWpGaD
Duloxetine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.00856	0.00856	CbGpPWpGaD
Duloxetine—NPY1R—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.00852	0.00852	CbGpPWpGaD
Duloxetine—NPY1R—GPCR ligand binding—CXCR2—periodontitis	0.00838	0.00838	CbGpPWpGaD
Duloxetine—CYP1A2—Aflatoxin activation and detoxification—GGT1—periodontitis	0.00824	0.00824	CbGpPWpGaD
Duloxetine—CYP2D6—Melatonin metabolism and effects—ADRB1—periodontitis	0.00799	0.00799	CbGpPWpGaD
Duloxetine—CYP1A2—Estrogen Receptor Pathway—PPARA—periodontitis	0.00799	0.00799	CbGpPWpGaD
Duloxetine—SLC6A4—Monoamine Transport—IL1B—periodontitis	0.00777	0.00777	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—CXCL3—periodontitis	0.00735	0.00735	CbGpPWpGaD
Duloxetine—HTR2A—GPCRs, Other—CXCR2—periodontitis	0.00698	0.00698	CbGpPWpGaD
Duloxetine—CYP1A2—Melatonin metabolism and effects—ADRB1—periodontitis	0.00677	0.00677	CbGpPWpGaD
Duloxetine—SLC6A2—Monoamine Transport—IL1B—periodontitis	0.00668	0.00668	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—CXCL3—periodontitis	0.00668	0.00668	CbGpPWpGaD
Duloxetine—SLC6A4—SIDS Susceptibility Pathways—IL13—periodontitis	0.00667	0.00667	CbGpPWpGaD
Duloxetine—HTR6—G alpha (s) signalling events—ADRB1—periodontitis	0.0066	0.0066	CbGpPWpGaD
Duloxetine—NPY1R—GPCR ligand binding—CCR2—periodontitis	0.00652	0.00652	CbGpPWpGaD
Duloxetine—NPY1R—GPCR ligand binding—ADRB1—periodontitis	0.00649	0.00649	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.0063	0.0063	CbGpPWpGaD
Duloxetine—NPY1R—Peptide ligand-binding receptors—CCL2—periodontitis	0.00629	0.00629	CbGpPWpGaD
Duloxetine—SLC6A3—Monoamine Transport—IL1B—periodontitis	0.00592	0.00592	CbGpPWpGaD
Duloxetine—SLC6A4—SIDS Susceptibility Pathways—IL1RN—periodontitis	0.00583	0.00583	CbGpPWpGaD
Duloxetine—SLC6A4—Monoamine Transport—TNF—periodontitis	0.00564	0.00564	CbGpPWpGaD
Duloxetine—SLC6A4—NRF2 pathway—GGT1—periodontitis	0.00533	0.00533	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—VIP—periodontitis	0.00532	0.00532	CbGpPWpGaD
Duloxetine—NPY1R—Peptide ligand-binding receptors—CXCL8—periodontitis	0.00497	0.00497	CbGpPWpGaD
Duloxetine—SLC6A2—Monoamine Transport—TNF—periodontitis	0.00485	0.00485	CbGpPWpGaD
Duloxetine—SLC6A3—Dopaminergic Neurogenesis—TGFB1—periodontitis	0.00485	0.00485	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—VIP—periodontitis	0.00483	0.00483	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—CXCL3—periodontitis	0.0048	0.0048	CbGpPWpGaD
Duloxetine—HTR6—GPCRs, Class A Rhodopsin-like—CXCR2—periodontitis	0.00474	0.00474	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—CXCR2—periodontitis	0.00474	0.00474	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.00464	0.00464	CbGpPWpGaD
Duloxetine—SLC6A2—NRF2 pathway—GGT1—periodontitis	0.00458	0.00458	CbGpPWpGaD
Duloxetine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—periodontitis	0.00439	0.00439	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—CXCR2—periodontitis	0.0043	0.0043	CbGpPWpGaD
Duloxetine—SLC6A3—Monoamine Transport—TNF—periodontitis	0.0043	0.0043	CbGpPWpGaD
Duloxetine—SLC6A4—NRF2 pathway—AGER—periodontitis	0.00424	0.00424	CbGpPWpGaD
Duloxetine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.00422	0.00422	CbGpPWpGaD
Duloxetine—SLC6A4—SIDS Susceptibility Pathways—IL1A—periodontitis	0.0042	0.0042	CbGpPWpGaD
Duloxetine—NPY1R—G alpha (i) signalling events—CXCL8—periodontitis	0.0042	0.0042	CbGpPWpGaD
Duloxetine—SLC6A4—SIDS Susceptibility Pathways—IL10—periodontitis	0.00417	0.00417	CbGpPWpGaD
Duloxetine—SLC6A3—NRF2 pathway—GGT1—periodontitis	0.00406	0.00406	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.00406	0.00406	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.00403	0.00403	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—IL13—periodontitis	0.00402	0.00402	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—CXCL3—periodontitis	0.00394	0.00394	CbGpPWpGaD
Duloxetine—SLC6A4—Circadian rythm related genes—NTRK1—periodontitis	0.0039	0.0039	CbGpPWpGaD
Duloxetine—CYP1A2—Arachidonic acid metabolism—GGT1—periodontitis	0.0038	0.0038	CbGpPWpGaD
Duloxetine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—periodontitis	0.0037	0.0037	CbGpPWpGaD
Duloxetine—HTR6—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.00369	0.00369	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—CCR2—periodontitis	0.00368	0.00368	CbGpPWpGaD
Duloxetine—HTR6—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	0.00367	0.00367	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—ADRB1—periodontitis	0.00367	0.00367	CbGpPWpGaD
Duloxetine—SLC6A2—NRF2 pathway—AGER—periodontitis	0.00365	0.00365	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—CXCL3—periodontitis	0.00353	0.00353	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—IL1RN—periodontitis	0.00351	0.00351	CbGpPWpGaD
Duloxetine—HTR2C—GPCRs, Class A Rhodopsin-like—CXCR2—periodontitis	0.00349	0.00349	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—CCR2—periodontitis	0.00335	0.00335	CbGpPWpGaD
Duloxetine—NPY1R—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.00334	0.00334	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—ADRB1—periodontitis	0.00333	0.00333	CbGpPWpGaD
Duloxetine—SLC6A3—NRF2 pathway—AGER—periodontitis	0.00323	0.00323	CbGpPWpGaD
Duloxetine—NPY1R—GPCR ligand binding—CCL2—periodontitis	0.00321	0.00321	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.00316	0.00316	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.00314	0.00314	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—CXCR2—periodontitis	0.00309	0.00309	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—CXCL3—periodontitis	0.00307	0.00307	CbGpPWpGaD
Duloxetine—HTR2A—GPCRs, Class A Rhodopsin-like—CXCR2—periodontitis	0.00303	0.00303	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.00299	0.00299	CbGpPWpGaD
Duloxetine—SLC6A4—Circadian rythm related genes—PPARA—periodontitis	0.00295	0.00295	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—VIP—periodontitis	0.00285	0.00285	CbGpPWpGaD
Duloxetine—HTR2C—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.00271	0.00271	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—CXCL3—periodontitis	0.00271	0.00271	CbGpPWpGaD
Duloxetine—HTR2C—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	0.0027	0.0027	CbGpPWpGaD
Duloxetine—SLC6A4—Circadian rythm related genes—NOS2—periodontitis	0.00261	0.00261	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.0026	0.0026	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—CXCR2—periodontitis	0.00254	0.00254	CbGpPWpGaD
Duloxetine—NPY1R—GPCR ligand binding—CXCL8—periodontitis	0.00254	0.00254	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—MMP3—periodontitis	0.00254	0.00254	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—IL1A—periodontitis	0.00253	0.00253	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—IL10—periodontitis	0.00251	0.00251	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CXCL3—periodontitis	0.00246	0.00246	CbGpPWpGaD
Duloxetine—CYP1A2—Phase II conjugation—GGT1—periodontitis	0.00242	0.00242	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—CCR2—periodontitis	0.00241	0.00241	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—ADRB1—periodontitis	0.00239	0.00239	CbGpPWpGaD
Duloxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—periodontitis	0.00238	0.00238	CbGpPWpGaD
Duloxetine—HTR2A—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.00236	0.00236	CbGpPWpGaD
Duloxetine—HTR2A—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	0.00235	0.00235	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.00233	0.00233	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.00232	0.00232	CbGpPWpGaD
Duloxetine—SLC6A4—SIDS Susceptibility Pathways—CXCL8—periodontitis	0.00228	0.00228	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—CXCR2—periodontitis	0.00228	0.00228	CbGpPWpGaD
Duloxetine—SLC6A4—SIDS Susceptibility Pathways—IL1B—periodontitis	0.00219	0.00219	CbGpPWpGaD
Duloxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—periodontitis	0.00207	0.00207	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.00202	0.00202	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.00201	0.00201	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CXCL3—periodontitis	0.002	0.002	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—CXCR2—periodontitis	0.00198	0.00198	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—CCR2—periodontitis	0.00198	0.00198	CbGpPWpGaD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—periodontitis	0.00197	0.00197	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—ADRB1—periodontitis	0.00197	0.00197	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—VIP—periodontitis	0.00196	0.00196	CbGpPWpGaD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—periodontitis	0.00189	0.00189	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CXCL3—periodontitis	0.00181	0.00181	CbGpPWpGaD
Duloxetine—SLC6A4—NRF2 pathway—TGFB1—periodontitis	0.00179	0.00179	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—VIP—periodontitis	0.00178	0.00178	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—CCR2—periodontitis	0.00177	0.00177	CbGpPWpGaD
Duloxetine—CYP1A2—Arachidonic acid metabolism—PTGS2—periodontitis	0.00177	0.00177	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—ADRB1—periodontitis	0.00176	0.00176	CbGpPWpGaD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—periodontitis	0.00176	0.00176	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—CXCR2—periodontitis	0.00175	0.00175	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CXCL3—periodontitis	0.00173	0.00173	CbGpPWpGaD
Duloxetine—CYP2D6—Biological oxidations—GGT1—periodontitis	0.00167	0.00167	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—CCL2—periodontitis	0.00165	0.00165	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—NTRK1—periodontitis	0.00161	0.00161	CbGpPWpGaD
Duloxetine—SLC6A4—SIDS Susceptibility Pathways—TNF—periodontitis	0.00159	0.00159	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CXCR2—periodontitis	0.00159	0.00159	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CXCL3—periodontitis	0.00157	0.00157	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.00156	0.00156	CbGpPWpGaD
Duloxetine—SLC6A2—NRF2 pathway—TGFB1—periodontitis	0.00154	0.00154	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—CCR2—periodontitis	0.00154	0.00154	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—ADRB1—periodontitis	0.00153	0.00153	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—MMP3—periodontitis	0.0015	0.0015	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CXCL3—periodontitis	0.00145	0.00145	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—VIP—periodontitis	0.00144	0.00144	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—CXCL8—periodontitis	0.00144	0.00144	CbGpPWpGaD
Duloxetine—CYP1A2—Biological oxidations—GGT1—periodontitis	0.00141	0.00141	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—CXCL8—periodontitis	0.00137	0.00137	CbGpPWpGaD
Duloxetine—SLC6A3—NRF2 pathway—TGFB1—periodontitis	0.00137	0.00137	CbGpPWpGaD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—periodontitis	0.00137	0.00137	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—CCR2—periodontitis	0.00136	0.00136	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—ADRB1—periodontitis	0.00135	0.00135	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—IL1B—periodontitis	0.00132	0.00132	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—VIP—periodontitis	0.00131	0.00131	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—CXCL8—periodontitis	0.0013	0.0013	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CXCR2—periodontitis	0.00129	0.00129	CbGpPWpGaD
Duloxetine—SLC6A4—SIDS Susceptibility Pathways—IL6—periodontitis	0.00128	0.00128	CbGpPWpGaD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—periodontitis	0.00128	0.00128	CbGpPWpGaD
Duloxetine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—periodontitis	0.00128	0.00128	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—VIP—periodontitis	0.00125	0.00125	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CCR2—periodontitis	0.00123	0.00123	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.00123	0.00123	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—ADRB1—periodontitis	0.00123	0.00123	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—CCL2—periodontitis	0.00119	0.00119	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CXCR2—periodontitis	0.00117	0.00117	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.00115	0.00115	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—VIP—periodontitis	0.00114	0.00114	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CXCR2—periodontitis	0.00112	0.00112	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CXCL3—periodontitis	0.00107	0.00107	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—VIP—periodontitis	0.00105	0.00105	CbGpPWpGaD
Duloxetine—SLC6A2—Transmembrane transport of small molecules—PPARA—periodontitis	0.00105	0.00105	CbGpPWpGaD
Duloxetine—SLC6A4—Circadian rythm related genes—IL6—periodontitis	0.00105	0.00105	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CXCR2—periodontitis	0.00101	0.00101	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CCR2—periodontitis	0.001	0.001	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—ADRB1—periodontitis	0.000996	0.000996	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.000995	0.000995	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—CCL2—periodontitis	0.000974	0.000974	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—TNF—periodontitis	0.000956	0.000956	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CXCR2—periodontitis	0.000938	0.000938	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—CXCL8—periodontitis	0.000937	0.000937	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—MMP3—periodontitis	0.000935	0.000935	CbGpPWpGaD
Duloxetine—SLC6A3—Transmembrane transport of small molecules—PPARA—periodontitis	0.000931	0.000931	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CXCL3—periodontitis	0.00093	0.00093	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CCR2—periodontitis	0.000909	0.000909	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.000906	0.000906	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—ADRB1—periodontitis	0.000905	0.000905	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—FGF2—periodontitis	0.00088	0.00088	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—CCL2—periodontitis	0.000873	0.000873	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—SLC52A3—periodontitis	0.00087	0.00087	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CCR2—periodontitis	0.000869	0.000869	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—ADRB1—periodontitis	0.000865	0.000865	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CCR2—periodontitis	0.000789	0.000789	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.000787	0.000787	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—ADRB1—periodontitis	0.000786	0.000786	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—VIP—periodontitis	0.000775	0.000775	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—IL6—periodontitis	0.000772	0.000772	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—CXCL8—periodontitis	0.00077	0.00077	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—CCL2—periodontitis	0.000758	0.000758	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—SLC52A3—periodontitis	0.000737	0.000737	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—IL6—periodontitis	0.000732	0.000732	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CCR2—periodontitis	0.000729	0.000729	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—ADRB1—periodontitis	0.000726	0.000726	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—MMP9—periodontitis	0.000696	0.000696	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CXCR2—periodontitis	0.00069	0.00069	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—CXCL8—periodontitis	0.00069	0.00069	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—MMP3—periodontitis	0.000689	0.000689	CbGpPWpGaD
Duloxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	0.000687	0.000687	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—VIP—periodontitis	0.000673	0.000673	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CCL2—periodontitis	0.000608	0.000608	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CXCR2—periodontitis	0.0006	0.0006	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—CXCL8—periodontitis	0.000599	0.000599	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—MMP3—periodontitis	0.000598	0.000598	CbGpPWpGaD
Duloxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	0.000597	0.000597	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—NTRK1—periodontitis	0.000594	0.000594	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—TGFB1—periodontitis	0.000574	0.000574	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—MMP3—periodontitis	0.000553	0.000553	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—periodontitis	0.000543	0.000543	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CCR2—periodontitis	0.000537	0.000537	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—ADRB1—periodontitis	0.000535	0.000535	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—CXCL8—periodontitis	0.00053	0.00053	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ACP5—periodontitis	0.000513	0.000513	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CXCL8—periodontitis	0.000481	0.000481	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CCR2—periodontitis	0.000466	0.000466	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—ADRB1—periodontitis	0.000464	0.000464	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CCL2—periodontitis	0.000448	0.000448	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—NTRK1—periodontitis	0.000438	0.000438	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ACP5—periodontitis	0.000435	0.000435	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—IL6—periodontitis	0.000433	0.000433	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—MMP3—periodontitis	0.000407	0.000407	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CXCL8—periodontitis	0.00039	0.00039	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CCL2—periodontitis	0.000389	0.000389	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—periodontitis	0.000388	0.000388	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—NTRK1—periodontitis	0.00038	0.00038	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CCL2—periodontitis	0.000359	0.000359	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CXCL8—periodontitis	0.000354	0.000354	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—MMP3—periodontitis	0.000353	0.000353	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CXCL8—periodontitis	0.000339	0.000339	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—FGF2—periodontitis	0.000325	0.000325	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CXCL8—periodontitis	0.000307	0.000307	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—GGT1—periodontitis	0.000285	0.000285	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CXCL8—periodontitis	0.000284	0.000284	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—IL6—periodontitis	0.00027	0.00027	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CCL2—periodontitis	0.000265	0.000265	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—MMP9—periodontitis	0.000257	0.000257	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	0.000253	0.000253	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—GGT1—periodontitis	0.000242	0.000242	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—FGF2—periodontitis	0.000239	0.000239	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CCL2—periodontitis	0.00023	0.00023	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—TGFB1—periodontitis	0.000212	0.000212	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CXCL8—periodontitis	0.000209	0.000209	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—FGF2—periodontitis	0.000208	0.000208	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—PPARA—periodontitis	0.000204	0.000204	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—IL6—periodontitis	0.000199	0.000199	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—MMP9—periodontitis	0.000189	0.000189	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CXCL8—periodontitis	0.000182	0.000182	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—PPARA—periodontitis	0.000173	0.000173	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—IL6—periodontitis	0.000173	0.000173	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—MMP9—periodontitis	0.000164	0.000164	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—IL6—periodontitis	0.00016	0.00016	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—TGFB1—periodontitis	0.000156	0.000156	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—TGFB1—periodontitis	0.000135	0.000135	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—PTGS2—periodontitis	0.000133	0.000133	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—IL6—periodontitis	0.000118	0.000118	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—PTGS2—periodontitis	0.000112	0.000112	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—IL6—periodontitis	0.000102	0.000102	CbGpPWpGaD
